NIOX Group Plc

LSE NIOX.L

NIOX Group Plc Return on Assets (ROA) for the year ending December 30, 2023: 11.69%

NIOX Group Plc Return on Assets (ROA) is 11.69% for the year ending December 30, 2023, a -28.46% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • NIOX Group Plc Return on Assets (ROA) for the year ending December 30, 2022 was 16.35%, a 292.28% change year over year.
  • NIOX Group Plc Return on Assets (ROA) for the year ending December 30, 2021 was 4.17%, a 112.82% change year over year.
  • NIOX Group Plc Return on Assets (ROA) for the year ending December 30, 2020 was -32.49%, a -377.33% change year over year.
  • NIOX Group Plc Return on Assets (ROA) for the year ending December 30, 2019 was -6.81%.
Key data
Date Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio
Market news
LSE: NIOX.L

NIOX Group Plc

CEO Mr. Ian Roy Johnson
IPO Date March 13, 2014
Location United Kingdom
Headquarters Hayakawa Building
Employees 92
Sector Health Care
Industries
Pharmaceuticals Biotechnology Medical Instruments
Description

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

StockViz Staff

January 16, 2025

Any question? Send us an email